|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1650 Diagonal Road |
Address2 |
|
City | ALEXANDRIA |
State | VA |
Zip Code | 22314 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1386-12
|
||||||||
|
6. House ID# 321810000
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: James C. Denneny III, MD |
Date | 7/20/2020 2:19:50 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Coalition letter addressed to the Secretary of the U.S. Department of Health and Human Services urging HHS to provide one month of revenue to each physician, nurse practitioner, and physician assistant enrolled in Medicare or Medicaid to account for financial losses and non-reimbursable expenses.
Coalition letter addressed to House Speaker Pelosi, House Minority Leader McCarthy, Senate Majority Leader McConnell, and Senate Minority Leader Schumer urging support for physicians by including provisions such as student loan relief, medical liability protections, supply chain support and others in a future COVID-19 legislative package.
Coalition letter addressed to Quality Measurement and Value-Based Incentives Group urging CMS to encourage clinicians and groups to report under the Merit-Based Incentive Payment System using Qualified Clinical Data Registries.
Coalition letter addressed to House Speaker Pelosi, House Minority Leader McCarthy, Senate Majority Leader McConnell, and Senate Minority Leader Schumer asking to preserve viability of physician practices by including certain provisions in any upcoming COVID-19 legislation.
Coalition letter addressed to House Speaker Pelosi, House Minority Leader McCarthy, Senate Majority Leader McConnell, and Senate Minority Leader Schumer urging Congress to include language from H.R. 7059, the Coronavirus Provider Protection Act that would provide liability protections for physicians in the next COVID-19 legislative package.
Coalition letter addressed to Rep. Phil Roe, M.D. and Lou Correa thanking them for introduction and expressing support for H.R. 7059, the Coronavirus Provider Protection Act.
Coalition letter addressed to the Administrator of the Center for Medicare & Medicaid Services stating opposition to expanding the scope of services NPPs furnish in IRFs, and urging CMS to uphold the role of the rehabilitation physician in delivering and overseeing care for patients in IRF settings.
Coalition letter addressed to Representatives Diana DeGette and Fred Upton requesting to include in any upcoming COVID-19 legislation language guaranteeing clinical data registries access to Medicare claims data for quality improvement, patient safety, and research purposes, all of which are necessary to build an evidence-based shift to value-based care.
H.R. 4056 and S. 2446, the "Medicare Audiologist Access and Services Act," all provisions.
H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, section 602.
H.R. 3502, the Protecting People from Surprise Medical Bills Act, all provisions.
S.1531, the STOP Surprise Medical Bills Act, To amend the Public Health Service Act to provide protections for health insurance consumers from surprise billing, all provisions.
S. 1895, the Lower Health Care Costs Act, to lower health care costs, all provisions.
H.R.3630, the No Surprises Act, to protect health care consumers from surprise billing practices, and for other purposes, all provisions.
H.R. 663, the Truth in Healthcare Marketing Act of 2020, all provisions.
H.R. 7059, the "Coronavirus Provider Protection Act," all provisions.
Issues pertaining to the COVID-19 pandemic, in general.
Issues related to hearing healthcare; in general.
Issues pertaining to health information technology and electronic health records; in general.
Issues pertaining to the Early Detection and Intervention (EHDI) program, in general.
Issues pertaining to scope of practice legislation; in general.
Federal "Truth in Advertising" Legislation; in general.
Issues pertaining to Language Equality and Acquisition for Deaf Kids (LEAD-K) and parent choice; in general.
Issues pertaining to surprise out of network bills, in general.
Issues pertaining to Graduate Medical Education; in general.
Issues pertaining to healthcare liability reform, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
Ruth |
Hazdovac |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Coalition letter addressed to the Secretary of the U.S. Department of Health and Human Services urging HHS to provide one month of revenue to each physician, nurse practitioner, and physician assistant enrolled in Medicare or Medicaid to account for financial losses and non-reimbursable expenses.
Coalition letter addressed to House Speaker Pelosi, House Minority Leader McCarthy, Senate Majority Leader McConnell, and Senate Minority Leader Schumer urging support for physicians by including provisions such as student loan relief, medical liability protections, supply chain support and others in a future COVID-19 legislative package.
Coalition letter addressed to Quality Measurement and Value-Based Incentives Group urging CMS to encourage clinicians and groups to report under the Merit-Based Incentive Payment System using Qualified Clinical Data Registries.
Coalition letter addressed to House Speaker Pelosi, House Minority Leader McCarthy, Senate Majority Leader McConnell, and Senate Minority Leader Schumer asking to preserve viability of physician practices by including certain provisions in any upcoming COVID-19 legislation.
Coalition letter addressed to the Administrator of the Center for Medicare & Medicaid Services stating opposition to expanding the scope of services NPPs furnish in IRFs, and urging CMS to uphold the role of the rehabilitation physician in delivering and overseeing care for patients in IRF settings.
Coalition letter addressed to Representatives Diana DeGette and Fred Upton requesting to include in any upcoming COVID-19 legislation language guaranteeing clinical data registries access to Medicare claims data for quality improvement, patient safety, and research purposes, all of which are necessary to build an evidence-based shift to value-based care.
H.R. 4056 and S. 2446, the "Medicare Audiologist Access and Services Act," all provisions.
H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, section 602.
H.R. 3502, the Protecting People from Surprise Medical Bills Act, all provisions.
S.1531, the STOP Surprise Medical Bills Act, To amend the Public Health Service Act to provide protections for health insurance consumers from surprise billing, all provisions.
S. 1895, the Lower Health Care Costs Act, to lower health care costs, all provisions.
H.R.3630, the No Surprises Act, to protect health care consumers from surprise billing practices, and for other purposes, all provisions.
Issues pertaining to scope of practice legislation; in general.
Issues related to hearing healthcare; in general.
Issues pertaining to health information technology and electronic health records; in general.
Issues pertaining to the Early Detection and Intervention (EHDI) program, in general.
Issues pertaining to surprise out of network bills, in general.
Issues pertaining to the COVID-19 pandemic, in general.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Maura |
Farrell |
|
|
|
Ruth |
Hazdovac |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |